Fuchs Vidmante, Kutza Michael, Wischnewski Sven, Deigendesch Nikolaus, Lutz Luc, Kulsvehagen Laila, Ricken Gerda, Kappos Ludwig, Tzankov Alexandar, Hametner Simon, Frank Stephan, Schirmer Lucas, Pröbstel Anne-Katrin
From the Multiple Sclerosis Center (V.F., L.L., L. Kulsvehagen, L. Kappos), Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, and Biomedicine, University Hospital and University of Basel, Switzerland; Department of Neurology (M.K., S.W., L.S.), Medical Faculty Mannheim, Heidelberg University, Germany; Pathology (N.D., A.T., S.F.), Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Switzerland; Department of Neurology (G.R., S.H.), Division of Neuropathology and Neurochemistry, Medical University Vienna, Austria; Mannheim Center for Translational Neuroscience and Institute for Innate Immunoscience (L.S.), Medical Faculty Mannheim, Heidelberg University, Germany; and Interdisciplinary Center for Neurosciences (L.S.), Heidelberg University, Germany.
Neurol Neuroimmunol Neuroinflamm. 2021 Jan 27;8(2). doi: 10.1212/NXI.0000000000000957. Print 2021 Mar 4.
